Life sciences organizations often describe their hiring challenge as a speed problem. Roles stay open too long, pipelines stall, and critical leadership positions take months to close. Yet in practice, the slowdown is rarely caused by a lack of urgency. It is almost always a lack of alignment on what “good” looks like once a candidate is in front of decision-makers.
This becomes especially visible during periods of rapid scaling. As biotech and pharma companies transition from discovery to development or commercialization, the decision-making framework that worked at 50 employees starts to break down. Suddenly, multiple stakeholders weigh in with different expectations, and hiring slows not because of process inefficiency, but because no shared definition of success exists.
In many cases, organizations attempt to solve this by tightening timelines or adding structure to interview loops. But structure without clarity only accelerates disagreement. The real constraint is not operational; it is interpretive. Leaders are not aligned on what the role needs to accomplish in the next 18–24 months, particularly in volatile scientific or regulatory environments.
This is where many hiring processes quietly lose momentum. A candidate may meet every stated requirement yet still fail to advance because the organization is subconsciously comparing them to different versions of the role. One stakeholder is hiring for immediate execution, another for long-term transformation capability. Without alignment, every strong candidate becomes a debate rather than a decision.
We see this pattern repeatedly in scaling organizations attempting to move from strong science to disciplined execution. As explored in When great science plateaus the leadership challenge behind scaling, the transition point is often less about scientific capability and more about leadership coherence.
What makes this even more complex is that delay itself begins to distort perception. The longer a role stays open, the more idealized the candidate profile becomes. Each new conversation adds another layer of expectation, often disconnected from the realities of the market. By the time a decision is finally made, the organization is no longer hiring for the role as it was originally defined, but for an evolving and sometimes unrealistic composite.
The irony is that speed improves naturally once clarity is established. When stakeholders agree on the non-negotiables like what the role must deliver, what trade-offs are acceptable, and what success looks like in practice, decision cycles shorten without procedural intervention. The constraint dissolves because the ambiguity has been removed.
In high-performing life sciences companies, hiring is not faster because people rush. It is faster because alignment happens earlier and more deliberately. The conversation shifts from evaluating candidates in isolation to testing them against a shared strategic lens.
Ultimately, hiring outcomes reflect decision quality more than process efficiency. Organizations that treat delays as a symptom of speed miss the underlying issue. Those that address clarity directly tend to find that speed follows naturally.
GeneCoda® works with life sciences organizations navigating exactly these transition points, helping leadership teams translate ambiguity into aligned hiring decisions that support scalable growth and execution discipline.
